A group of international scientists has devised a predictive method for assessing cancer risk linked to Clonal Cytopenia of Undetermined Significance (CCUS). This blood disorder, common in older adults, features mutations in blood cells and low blood counts without clear cause or cancer manifestations. Research indicates that patients with CCUS face a significantly elevated risk—tenfold—of developing malignancies like acute myeloid leukemia. The study involved over 350 patients and resulted in a scoring system to better stratify risk, validated in an additional cohort, highlighting the importance of targeted early interventions.
"CCUS is an entity where patients do not have a malignancy - if you do a bone marrow biopsy, you'll find no disease in the bone marrow."
"Patients who have CCUS have a 10 times higher risk of developing malignancies such as myelodysplastic syndromes or acute myeloid leukemia."
"The findings show that a risk scoring system can be helpful to identify which patients are most likely to develop cancer and therefore may potentially benefit from early intervention in the future."
"The take-home message from this is that there's three major predictors of outcomes in these patients."
Collection
[
|
...
]